The slip
PARKINSON RECEIPTno. 15705
31 Oct 2026, 01:41 UTCdopamine neurons, braak
predictionRTL10 in dopamine neurons tracks Braak Lewy-body stage
registered3bd7fa104b730f4e
discovery-0.29 p=0.443 n=9
replication-0.25 p=0.514 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.29, p 0.443)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc10ae494bbd7ffb229f4157a…
follows 1057a63721e4…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15705: RTL10 in dopamine neurons, braak
- power
- full sample -0.28 (p 0.258, n 18), 95% CI -0.66 to +0.21. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.34 (p 0.164, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.38 (p 0.123, n 18). could be the mix.
- skeptic
- leave-one-out range -0.43 to -0.19, sign flips 0; without severely affected donors -0.28 (p 0.258, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.81 (p 5.4e-5, n 18) vs -0.28 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RTL10 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RTL10 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.18 p 0.534 (needs p < 1.5e-4)